title: Complete suppresion of ethanol-induced formation of megamitochondria by 4-hydroxy-2,2,6,6-tetramethyl-piperidine-1-oxyl (4-OH-TEMPO).
abstract: An attempt has been made to suppress the ethanol-induced formation of megamitochondria (MG) in the rat liver by 4-hydroxy-2,2,6,6-tetramethyl-piperidine-1-oxyl (4-OH-TEMPO), a free radical scavenger, and by allopurinol (AP), a xanthine oxidase inhibitor. Changes observed in the liver of animals given ethanol (EtOH) for 1 month were remarkable decreases both in the body weight gains during the course of the experiment and in the liver weight at the time of sacrifice compared to those of the control; remarkable increases in the level of thiobarbituric acid reactive substances and lipid soluble fluorophores both in microsomes and mitochondria; decreases in the content of cytochrome a+a3 and b and lowered phosphorylating ability of mitochondria; and formation of MG in the liver. A combined treatment of animals with EtOH plus 4-OH-TEMPO completely suppressed the formation of MG in the liver induced by EtOH and distinctly improved the changes caused by EtOH, as specified above, while AP partly suppressed the MG formation. Results described herein provide additional insight into chronic hepatotoxicity of EtOH besides that previously reported. A novelty of the present work is that we were able for the first time to demonstrate reversibility of EtOH-mediated ultrastructural changes of the liver by a simple administration of aminoxyl-type free radical scavenger, 4-OH-TEMPO. Our results suggest that free radicals may be involved in the mechanism of the formation of MG induced by EtOH.
authors.affiliation: Department of Cell Biology and Molecular Pathology, Nagoya University School of Medicine, Japan.
authors.forename: T
authors.initials: T
authors.lastname: Matsuhashi
authors.forename: M
authors.initials: M
authors.lastname: Karbowski
authors.forename: X
authors.initials: X
authors.lastname: Liu
authors.forename: J
authors.initials: J
authors.lastname: Usukura
authors.forename: M
authors.initials: M
authors.lastname: Wozniak
authors.forename: T
authors.initials: T
authors.lastname: Wakabayashi
mesh_terms: D000493:Allopurinol / Q000494:pharmacology; D000818:Animals; D003497:Cyclic N-Oxides / Q000494:pharmacology*; D003580:Cytochromes / Q000378:metabolism; D003864:Depression, Chemical; D004791:Enzyme Inhibitors / Q000494:pharmacology; D000431:Ethanol / Q000037:antagonists & inhibitors*; D016166:Free Radical Scavengers / Q000494:pharmacology*; D005609:Free Radicals; D008297:Male; D008930:Mitochondria, Liver / Q000187:drug effects*; D009929:Organ Size / Q000187:drug effects; D010766:Phosphorylation; D051381:Rats; D017208:Rats, Wistar; D013113:Spin Labels; D015430:Weight Gain / Q000187:drug effects; D014969:Xanthine Oxidase / Q000037:antagonists & inhibitors
chemical_list: D003497:Cyclic N-Oxides; D003580:Cytochromes; D004791:Enzyme Inhibitors; D016166:Free Radical Scavengers; D005609:Free Radicals; D013113:Spin Labels; D000431:Ethanol; D000493:Allopurinol; D014969:Xanthine Oxidase; C001803:tempol